AIMC Topic: Angiogenesis Inhibitors

Clear Filters Showing 71 to 72 of 72 articles

Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach.

Investigative ophthalmology & visual science Jun 1, 2017
PURPOSE: The purpose of this study was to predict low and high anti-VEGF injection requirements during a pro re nata (PRN) treatment, based on sets of optical coherence tomography (OCT) images acquired during the initiation phase in neovascular AMD.
Humans Machine Learning Female Aged Aged, 80 and over Male Middle Aged Pilot Projects ROC Curve Angiogenesis Inhibitors Visual Acuity Predictive Value of Tests Tomography, Optical Coherence Vascular Endothelial Growth Factor A Macular Degeneration Ranibizumab Subretinal Fluid Choroidal Neovascularization
View on PubMed DOI

Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH Jan 1, 2016
BACKGROUND: Intravitreal bevacizumab has been shown to be an effective treatment of diabetic macular edema.
Humans Diabetic Retinopathy Angiogenesis Inhibitors Treatment Outcome Visual Acuity Corneal Topography Tomography, Optical Coherence Macular Edema Intravitreal Injections Recurrence Fluorescein Angiography Bevacizumab
View on PubMed DOI
Popular Topics
Recent Journals